US industry angered at CMS (Centers for Medicare and Medicaid Services) tactics on ICDs (implantable cardioverter defibrillators) reimbursement
This article was originally published in Clinica
Executive Summary
AdvaMed has raised "serious concerns" about the way Medicare's administrators have gone about soliciting comments on its policy regarding implantable cardioverter defibrillators (ICDs).